Marco Lobba
Co-Founder & Chief Executive Officer CatenaBio
Seminars
Tuesday 13th October 2026
Building for the Future: Enabling Dual Payload ADCs Without Off-Target Toxicity
3:30 pm
- Exploring how the CysTyr platform enables novel structures and payloads design for next-generation ADCs
- Leveraging precise DAR control to drive optimal ADC efficacy
- Beyond classical ADCs: Enabling next generation conjugate therapies
